Tetra Technologies Stock (NYSE:TTI), Trade Ideas

Tetra Technologies

Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. The Water & Flowback Services Division provides onshore oil and gas operators with comprehensive water management services. The company derives maximum revenue from United states.

Lithium.Shutterstock

Large Cap

News

Commodities

Exxon Mobil closed a successful year with $36 billion in earnings and plans to produce lithium for 1M EVs/year by 2030 through Mobil Lithium.

Exxon&#39;s Lithium Experiment Could Be Winner For Oil Company,  State Of Arkansas

Equities

Penny Stocks

Contracts

Small Cap

Markets

EOSE

Eos Energy Enterprises, Inc. (NASDAQ: EOSE) has broadened its collaboration with TETRA Technologies, Inc. (NYSE: TTI).

Eos Energy Amps Up Game With TETRA: Strategic Electrolyte Supply Deal Fuels Eos Z3 Cube Expansion

Intraday Update

Movers

Trading Ideas

ACRS

ALEC

APLD

AREB

BEAM

BWEN

BYND

CAUD

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CING

COMS

CREV

CTNT

CZOO

EDBL

EFTR

GCTK

INTZ

INVO

LIFW

LWAY

MNDY

MNPR

MNTK

MYNZ

NLSP

RILY

SNES

STNE

TCON

TENX

TIVC

TNON

VERV

VUZI

WETG

ZVSA

Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.

Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Tetra Technologies Inc

THIOGENESIS THERAPEUTICS by THIOGENESIS THERAPEUTICS CORP.

Thiogenesis Therapeutics Corp

TERTIARY MINERALS PLC ORD by Tertiary Minerals Plc

Tertiary Minerals PLC

EF Hutton analyst Tim Moore reiterates Tetra Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTI#NYSE">TTI</a>) with a Buy and maintains $9 price target.

Price Target

Reiteration

Analyst Ratings

EF Hutton Reiterates Buy on Tetra Technologies, Maintains $9 Price Target

WIIM

Tetra Technologies shares are trading higher after the company reported mixed Q4 financial results.

Tetra Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTI#NYSE">TTI</a>) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.06 by 50 percent. The company reported quarterly sales of $153.13 million which beat the analyst consensus estimate of $150.05 million by 2.05 percent. This is a 3.85 percent increase over sales of $147.45 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Tetra Technologies Q4 2023 Adj EPS $0.03 Misses $0.06 Estimate, Sales $153.13M Beat $150.05M Estimate

ACAD

ACHC

AESI

AHCO

AIRS

ALHC

AMBA

AMBC

APLS

ARKO

ARQT

ARRY

ATEC

AXON

BCSF

BECN

BGFV

BMBL

BWXT

CAVA

CBRL

CIVI

CLDT

CLNE

CLVT

CMLS

COMP

CPNG

CRDO

CYTK

EBAY

EHTH

ESPR

FARO

FLYW

FOUR

FSLR

FULC

GDOT

GLPI

GMRE

GSX Techedu Inc. American Depositary Shares

GOTU

GPOR

HRZN

HSIC

HURN

ICCC

ICFI

ICUI

IMAX

IMXI

INGN

INSE

IPAR

JAMF

KIND

KURA

KVYO

LAZR

LGND

LGVN

Earnings Scheduled For February 27, 2024

Northland Capital Markets analyst Greg Gibas initiates coverage on Tetra Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTI#NYSE">TTI</a>) with a Outperform rating and announces Price Target of $6.

Initiation

Northland Capital Markets Initiates Coverage On Tetra Technologies with Outperform Rating, Announces Price Target of $6

Exxon Mobil Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>)&#8217;s <a href="https://www.benzinga.com/news/earnings/24/02/36909483/exxons-q4-surprise-beats-earnings-expectations-despite-revenue-dip-embarks-on-bold-ev-and-lng-ventu">recent earnings announcement</a> closed up another successful year in which the company delivered $36 billion in earnings. 
Despite operating some of the most lucrative global oil projects, the company understands the inevitability of energy transition, deciding to launch a lithium operation in Arkansas.
Through Mobil Lithium, Exxon <a href="https://corporate.exxonmobil.com/news/news-releases/2023/1113_exxonmobil-drilling-first-lithium-well-in-arkansas">plans</a> to produce lithium for one million electric vehicles per year by 2030. This ambitious plan starts by choosing lithium filtration technology — including one of the unproven direct lithium extraction (DLE) technologies, which the company has been rigorously testing at a pilot plant in Houston.
Patrick Howarth, head of Exxon's lithium business, clarified the situation at the ongoing Arkansas Lithium Innovation Summit in Little Rock.
&#8220;DLE is a small part of a really complicated process that has many different steps. We&#8217;re really focused on how do they interact with one another,&#8221; he said in front of over 600 energy sector executives, policymakers and stakeholders participating in the inaugural conference.
Now read: <a href="https://www.benzinga.com/news/24/02/37156929/south32s-2-16b-mining-investment-in-arizona-supports-bidens-clean-energy-vision">South32&#8217;s $2.16B Mining Investment In Arizona Supports Biden&#8217;s Clean Energy Vision</a>
The direct lithium extraction method, involving the filtration of lithium directly from brine without traditional evaporation ponds, has been a key focus for Exxon. This innovative approach promises more cost-effective and environmentally responsible lithium production than conventional methods.
"This could be a big boom for our state,&#8221; Arkansas Gov. Sarah Huckabee Sanders told Reuters.
Environmental responsibility is the focus of local policymakers who support Exxon's desire to make Arkansas the epicenter of the domestic lithium industry.
&#8220;There are plenty of reasons for us to be bullish on Arkansas lithium. Frankly, we can do it cleaner here than it's produced anywhere else in the world. No strip mining or huge evaporation ponds. Just wells that extract brine straight out of the ground. We can ensure America has a supply of this critical material, almost all of which currently comes from overseas, in large part from our number one adversary," Sanders said.
Exxon is working in <a href="https://www.benzinga.com/news/large-cap/23/06/33054847/exxon-mobils-strategic-shift-enters-second-lithium-venture-in-bid-to-boost-us-ev-supply-chain">partnership with Tetra Technologies</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTI#NYSE">TTI</a>), an industry leader with patented technology for bromine production. A successful large-scale application of DLE technology would be a big win for Arkansas and a step forward in Exxon's diversification efforts.
Also Read: <a href="https://www.benzinga.com/news/24/02/37108506/sigma-lithium-secures-funds-for-brazilian-flagship-praises-significantly-lower-interest-rates">Sigma Lithium Secures Funds For Brazilian Flagship, Praises &#8216;Significantly Lower&#8217; Interest Rates</a> 
Photo: Shutterstock

Exxon's Lithium Experiment Could Be Winner For Oil Company,  State Of Arkansas

TETRA Technologies, Inc. (&quot;TETRA&quot; or the &quot;Company&quot;) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTI#NYSE">TTI</a>) announced that it has entered into a definitive agreement with Silver Point Finance (&quot;Silver Point&quot; or &quot;SPF&quot;) for a&nbsp;$265 million&nbsp;credit facility with a maturity of&nbsp;January 2030, consisting of a&nbsp;$190 million&nbsp;funded term loan and a&nbsp;$75 million&nbsp;delayed-draw term loan that will refinance TETRA&#39;s existing term loan of&nbsp;$163 million&nbsp;and provide capital to advance TETRA&#39;s&nbsp;Arkansas&nbsp;bromine processing project. Pricing on the new credit facility is&nbsp;SOFR (Secured Overnight Financing Rate) +575 basis points, which is 50 basis points below TETRA&#39;s existing term loan, reflecting TETRA&#39;s strong financial position. The new credit facility closed and funded on&nbsp;January 12, 2024. TETRA used the proceeds to repay in full the&nbsp;$163 million&nbsp;balance of its prior credit facility, that was due&nbsp;September 2025, with approximately&nbsp;$15 million&nbsp;of additional cash added to the balance sheet, net of transaction expenses.&nbsp;
TETRA anticipates that between its existing liquidity, which is estimated at&nbsp;$142 million&nbsp;as of&nbsp;January 12, 2024, and free cash flow that is expected to be generated from its existing base business in 2024 and 2025, plus the&nbsp;$75 million&nbsp;delayed draw term loan, that it has the required capital for the proposed&nbsp;Arkansas&nbsp;bromine processing project.&nbsp;
&quot;We are very pleased to partner with Silver Point to refinance our existing debt. Sourcing debt at more cost-effective rates than our previous term loan and extending the maturity to&nbsp;January 2030&nbsp;reflects TETRA&#39;s strong financial position and highly favorable prospects. Silver Point is providing the remaining capital we require to fund the bromine processing project with the&nbsp;$75 million&nbsp;delayed draw feature that TETRA can draw upon as we construct our bromine processing facility,&quot; said&nbsp;Brady Murphy, President and Chief Executive Officer of TETRA.

Financing

Tetra Technologies Announced $190M 6-year Funded Term Loan To Refinance Maturing Debt And A $75M Delayed Draw Term Loan To Provide Capital For The Planned Bromine Processing Project

Eos Energy Enterprises, Inc.&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eose#NASDAQ">EOSE</a>) has broadened its collaboration with&nbsp;TETRA Technologies, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tti#NYSE">TTI</a>). The two companies have been working together since 2021 to improve the quality of the electrolyte solution.
This expansion marks TETRA as the primary strategic supplier for Eos&#39;s American-made Eos Z3 energy storage cube. TETRA is set to supply at least 75% of the<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/24/01/g36553365/eos-energy-enterprises-and-tetra-technologies-inc-extend-partnership-expanding-electrolyte-product" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">&nbsp;electrolyte product needs moving forward.</a>
This four-year agreement, extendable beyond its initial term, includes favorable pricing and cost-saving methodologies, incentivizing both companies to pursue further cost reductions.
The high-purity zinc-bromide is central to the Eos Z3 cube&#39;s functionality, a component of Eos&#39;s patented electrolyte system. TETRA&#39;s U.S. patented manufacturing process delivers some of the highest zinc-bromide purity levels globally.
With the demand for Long Duration Energy Storage rising, Eos&#39;s partnership with TETRA is timely. TETRA&#39;s commitment to enhancing bromine production aligns with Eos&#39;s goals of scaling production, reducing costs, and enhancing battery performance and quality over the next few years.
Price Action:&nbsp;EOSE shares are trading lower by 5.32% at $0.9450, and TTI is down by 1.61% at $4.27 on Tuesday.
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via TETRA Technologies

Eos Energy Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) (&quot;Eos&quot;&nbsp;or the &quot;Company&quot;), a leading provider of safe, scalable, efficient, and sustainable zinc-based&nbsp;long duration&nbsp;energy storage systems,&nbsp;today&nbsp;expanded its partnership with TETRA Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTI#NYSE">TTI</a>) a leading global energy services and solutions company, designating TETRA as the preferred strategic supplier of electrolyte products for Eos&#39;s new, American made, Eos Z3&trade; long duration energy storage cube. TETRA is expected to supply a minimum of&nbsp;75%&nbsp;of the total electrolyte product demand going forward.
This four-year agreement is an expansion of an existing partnership between the two companies that began in 2021 and includes provisions that allow for extending the agreement beyond the initial four-year term. Eos and TETRA officials indicate that the agreement includes favorable pricing and cost savings allocation methodologies that motivate both parties to actively pursue further cost reductions.

Eos Energy Enterprises and TETRA Technologies, Extend Partnership, Expanding Electrolyte Production Capacity, Financial Terms Undisclosed

Edible Garden AG Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edbl#NASDAQ">EDBL</a>) shares fell on Monday following third-quarter results.
Edible Garden posted a quarterly loss of 69 cents per share, compared to a year-ago loss of $7.20 per share, <a href="http://pro.benzinga.com/">according to Benzinga Pro</a>. The company&rsquo;s quarterly sales came in at $3.29 million.
Edible Garden shares fell on Monday fell 17.6% to $0.5315 during Monday&rsquo;s session.
<h3>Gainers</h3>
<ul>
<li>Tenax Therapeutics, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tenx#NASDAQ">TENX</a>) shares jumped 130% to $0.3588 after the company announced FDA clearance of IND for TNX-103 for the treatment of pulmonary hypertension with heart failure with preserved ejection fraction.</li>
<li>Tivic Health Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tivc#NASDAQ">TIVC</a>) gained 81.3% to $2.1750. BestGrowthStocks.Com issued comprehensive analysis of Tivic Health Systems.</li>
<li>MSP Recovery, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lifw#NASDAQ">LIFW</a>) jumped 40.6% to $7.47.</li>
<li>ZyVersa Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zvsa#NASDAQ">ZVSA</a>) shares climbed 35.8% to $0.09.</li>
<li>Xos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xos#NASDAQ">XOS</a>) gained 26% to $0.42.</li>
<li>Collective Audience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/caud#NASDAQ">CAUD</a>) shares climbed 23.9% to $3.6801 after jumping around 30% on Friday.</li>
<li>Montauk Renewables, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mntk#NASDAQ">MNTK</a>) gained 23% to $7.91. Scotiabank upgraded Montauk Renewables from Sector Perform to Sector Outperform and announced a $9 price target.</li>
<li>Near Intelligence, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nir#NASDAQ">NIR</a>) shares climbed 21% to $0.23 after dipping 31% on Friday.</li>
<li>Cingulate Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cing#NASDAQ">CING</a>) gained 20.5% to $0.3798.</li>
<li>INVO Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/invo#NASDAQ">INVO</a>) rose 18% to $1.5400.</li>
<li>Cyngn Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyn#NASDAQ">CYN</a>) climbed 18% to $0.2011.</li>
<li>TETRA Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tti#NYSE">TTI</a>) gained 16.6% to $5.01. Exxon Mobil Corp is reportedly planning to unveil its long-awaited lithium strategy today. The company aims to produce at least 10,000 metric tons of lithium annually in Arkansas by 2026 in partnership with Tetra Technologies, with initial production roughly equivalent to the amount needed to produce 100,000 EV batteries, as per Reuters.</li>
<li>Cheetah Net Supply Chain Service Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctnt#NASDAQ">CTNT</a>) gained 15% to $1.30.</li>
<li>RLX Technology Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rlx#NYSE">RLX</a>) gained 15% to $1.8850.</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdio#NASDAQ">CDIO</a>) gained 14.7% to $1.17.</li>
<li>Karat Packaging Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/krt#NASDAQ">KRT</a>) gained 13.6% to $21.39. Karat Packaging recently reported worse-than-expected third-quarter revenue results.</li>
<li>Penumbra, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pen#NYSE">PEN</a>) surged 13.1% to $205.28.</li>
<li>COMSovereign Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coms#NASDAQ">COMS</a>) jumped 11.8% to $1.0398.</li>
<li>Tenon Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tnon#NASDAQ">TNON</a>) climbed 10.4% to $2.66.</li>
<li>monday.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mndy#NASDAQ">MNDY</a>) surged 9.9% to $154.03 following upbeat earnings.</li>
<li>StoneCo Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stne#NASDAQ">STNE</a>) gained 9.8% to $11.77 after the company reported upbeat results for its third quarter on Friday.</li>
<li>LQR House Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lqr#NASDAQ">LQR</a>) rose 9.4% to $0.23 after gaining around 8% on Friday. The company announced the pricing of a $11 million public offering of 157,142,857 shares at $0.07 per share.</li>
<li>SenesTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snes#NASDAQ">SNES</a>) shares gained 7.9% to $0.2580. SenesTech shares fell 31% on Friday after the company reported worse-than-expected third-quarter revenue results.</li>
<li>Cazoo Group Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/czoo#NYSE">CZOO</a>) shares gained 7.1% to $0.3749 after falling 11% on Friday.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Aclaris Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acrs#NASDAQ">ACRS</a>) shares dipped 86.8% to $0.6260 after the company announced topline results from 12-week Phase 2b trial of oral zunsemetinib for moderate to severe rheumatoid arthritis.</li>
<li>Mainz Biomed N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mynz#NASDAQ">MYNZ</a>) fell 45% to $1.23 after the company reported pricing of $5 million registered direct offering of 4,166,667 shares at $1.20 per share.</li>
<li>Verve Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verv#NASDAQ">VERV</a>) fell 45% to $8.65 after the company announced first human proof-of-concept data for in vivo base editing from the ongoing heart-1 phase 1b clinical trial of VERVE-101.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) dipped 25.1% to $19.17.</li>
<li>Safe and Green Development Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgd#NASDAQ">SGD</a>) shares fell 25% to $0.5252 after jumping 36% on Friday.</li>
<li>Carbon Revolution Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crev#NASDAQ">CREV</a>) declined 23.8% to $31.23.</li>
<li>Lifeway Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lway#NASDAQ">LWAY</a>) declined 22.8% to $9.73 following third-quarter results.</li>
<li>TRACON Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcon#NASDAQ">TCON</a>) fell 20.1% to $0.1840. TRACON Pharmaceuticals shares jumped 44% on Friday after the company reported third-quarter financial results.</li>
<li>Broadwind, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bwen#NASDAQ">BWEN</a>) fell 19% to $2.30 following weak sales.</li>
<li>Vuzix Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vuzi#NASDAQ">VUZI</a>) fell 19% to $2.08.</li>
<li>WeTrade Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wetg#NASDAQ">WETG</a>) declined 18.1% to $8.57.</li>
<li>NLS Pharmaceutics AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nlsp#NASDAQ">NLSP</a>) dipped 12.7% to $0.5448.</li>
<li>Beam Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/beam#NASDAQ">BEAM</a>) fell 12.1% to $19.49.</li>
<li>Intrusion Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intz#NASDAQ">INTZ</a>) fell 12% to $0.4217. The company announced that it entered into a Securities Purchase Agreement through a $2.4 million Private Offering of 4,359,374 shares at $0.60 per share.</li>
<li>Alector, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alec#NASDAQ">ALEC</a>) declined 10.8% to $4.01.</li>
<li>Monopar Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnpr#NASDAQ">MNPR</a>) dipped 10.5% to $0.3401 after falling over 8% on Friday. Monopar Therapeutics, last week, posted a narrower-than-expected quarterly loss.</li>
<li>GlucoTrack, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gctk#NASDAQ">GCTK</a>) shares fell 10.1% to $ 0.1420.</li>
<li>Applied Digital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apld#NASDAQ">APLD</a>) declined 10.1% to $4.2155.</li>
<li>WW International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ww#NASDAQ">WW</a>) fell 9.3% to $6.34. WW recently reported worse-than-expected third-quarter financial results.</li>
<li>eFFECTOR Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eftr#NASDAQ">EFTR</a>) shares fell 8% to $0.5425.</li>
<li>American Rebel Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/areb#NASDAQ">AREB</a>) fell 8% to $0.3250.</li>
<li>Beyond Meat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bynd#NASDAQ">BYND</a>) fell 7.4% to $6.40.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/11/35753030/aecom-likely-to-report-higher-q4-earnings-heres-a-look-at-recent-price-target-changes-by-the-most-a"> AECOM Likely To Report Higher Q4 Earnings; Here&#39;s A Look At Recent Price Target Changes By The Most Accurate Analysts</a>

Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session

U.S. stocks traded lower, with the Dow Jones falling around 40 points on Monday.
Shares of monday.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mndy#NASDAQ">MNDY</a>) gained on Monday <a href="https://www.benzinga.com/news/earnings/23/11/35746302/project-management-platform-monday-com-reports-robust-q3-topline-growth-stock-climbs">following upbeat earnings.</a>
Monday.com posted adjusted earnings of 64 cents per share, beating market estimates of 20 cents per share. The company&rsquo;s sales came in at $189.19 million versus expectations of $182.36 million.
The company said it sees Q4 revenue of $196 million to $198 million and FY23 revenue of $723 million to $725 million.
monday.com shares climbed 9.9% to $154.03 during Monday&rsquo;s session.
Here are some big stocks recording gains in today&rsquo;s session.
<ul>
<li>Montauk Renewables, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mntk#NASDAQ">MNTK</a>) shares jumped 23% to $7.91. Scotiabank upgraded Montauk Renewables from Sector Perform to Sector Outperform and announced a $9 price target.</li>
<li>TETRA Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tti#NYSE">TTI</a>) shares rose 16.6% to $5.01. Exxon Mobil Corp is reportedly planning to unveil its long-awaited lithium strategy today. The company aims to produce at least 10,000 metric tons of lithium annually in Arkansas by 2026 in partnership with Tetra Technologies, with initial production roughly equivalent to the amount needed to produce 100,000 EV batteries, as per Reuters.</li>
<li>RLX Technology Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rlx#NYSE">RLX</a>) jumped 15% to $1.88.</li>
<li>Karat Packaging Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/krt#NASDAQ">KRT</a>) rose 13.6% to $21.39. Karat Packaging recently reported worse-than-expected third-quarter revenue results.</li>
<li>Penumbra, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pen#NYSE">PEN</a>) gained 13.1% to $205.28.</li>
<li>Consensus Cloud Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ccsi#NASDAQ">CCSI</a>) gained 9.9% to $23.08. The company recently posted upbeat quarterly earnings.</li>
<li>StoneCo Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stne#NASDAQ">STNE</a>) rose 9.8% to $11.77 after the company reported upbeat results for its third quarter on Friday.</li>
<li>OneSpan Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ospn#NASDAQ">OSPN</a>) gained 8% to $10.28. OneSpan commenced a modified &quot;Dutch Auction&quot; tender offer to purchase for cash $20 million of its common stock at a price per share not less than $9.50 and not greater than $11.00.</li>
<li>Harmony Gold Mining Company Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hmy#NYSE">HMY</a>) rose 7.8% to $4.82.</li>
<li>Fortrea Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftre#NASDAQ">FTRE</a>) gained 6.4% to $30.00 following strong quarterly results.</li>
<li>Henry Schein, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hsic#NASDAQ">HSIC</a>) climbed 6.2% to $68.06 following third-quarter results.</li>
<li>Spirit Airlines, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/save#NYSE">SAVE</a>) jumped 5.7% to $9.28.</li>
<li>UP Fintech Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tigr#NASDAQ">TIGR</a>) gained 5.3% to $4.96.</li>
<li>The Boeing Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ba#NYSE">BA</a>) gained 4% to $204.38.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/23/11/35746303/top-4-consumer-stocks-that-may-fall-off-a-cliff-in-q4"> Top 4 Consumer Stocks That May Fall Off A Cliff In Q4</a>

CCSI

FTRE

OSPN

SAVE

TIGR

Monday.Com Reports Q3 Beat, Joins Fortrea Holdings, Henry Schein And Other Big Stocks Moving Higher On Monday

Exxon Mobil Corp&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xom#NYSE">XOM</a>) is reportedly planning to unveil its long-awaited lithium strategy today.&nbsp;
The company plans to start production of the electric vehicle (EV) battery metal in Arkansas by 2026, as per Reuters.
XOM is expanding into this&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">sector</a>&nbsp;to boost global production of ultralight metal by filtering it from salty brine deposits found globally and supplying it to battery makers.
The company aims to produce at least 10,000 metric tons of lithium annually in Arkansas by 2026 in partnership with&nbsp;Tetra Technologies Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tti#NYSE">TTI</a>), with initial production roughly equivalent to the amount needed to produce 100,000 EV batteries, as per the report.
Notably, earlier this year, XOM had agreed to develop over 6,100 lithium-rich acres in Arkansas with Tetra, as per Reuters.
Separate from its Tetra deal, the oil and gas giant also has more than 100,000 acres in Arkansas from which it plans to begin lithium production by 2027, per the report.
Last month, XOM reported Q3 FY23 adjusted net profit of $9.12 billion, or $2.27 per share,&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/news/earnings/23/10/35462875/oil-and-gas-giant-exxons-q3-profits-slump-to-9-1b-still-raises-annual-outlook" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">down from $18.682 billion, or $4.45 per share, a year earlier.&nbsp;</a>
Also Read:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/markets/equities/23/11/35731344/exxon-mobil-is-this-analysts-top-pick-citing-premium-valuation-relative-to-peers" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">Exxon Mobil Is This Analyst&#39;s Top Pick, Citing Premium Valuation Relative To Peers</a>
Price Action: XOM shares are trading higher by 0.31% at $104.07 premarket on the last check Monday.

Media

Exxon Mobil Plans To Start Lithium Production By 2026 In Arkansas: Report

<a href="https://www.reuters.com/markets/commodities/exxon-aims-begin-lithium-production-by-2026-arkansas-source-2023-11-11/#:~:text=Exxon%2C%20which%20invented%20the%20lithium,%2C%22%20according%20to%20the%20source" title="https://www.reuters.com/markets/commodities/exxon-aims-begin-lithium-production-by-2026-arkansas-source-2023-11-11/#:~:text=Exxon%2C%20which%20invented%20the%20lithium,%2C%22%20according%20to%20the%20source">https://www.reuters.com/markets/commodities/exxon-aims-begin-lithium-production-by-2026-arkansas-source-2023-11-11/#:~:text=Exxon%2C%20which%20invented%20the%20lithium,%2C%22%20according%20to%20the%20source</a>.

Rumors

Reuters Reported Saturday Exxon Mobil Plans To Produce 10,000 Metric Tons Of Lithium Annually By 2026 With Partner Tetra Technologies, Citing Sources

<h3>Gainers</h3>
<ul>
<li>SciSparc Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sprc#NASDAQ">SPRC</a>) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for Combination of Opioids and N-Acylethanolamines for pain treatment.</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdio#NASDAQ">CDIO</a>) gained 53.1% to $0.3264 after the company received an Innovation Technology contract from Vizient for its novel AI-driven precision heart disease tests.</li>
<li>Verve Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verv#NASDAQ">VERV</a>) jumped 27% to $11.95. Eli Lilly said it will acquire rights under Beam Therapeutics&rsquo; amended collaboration and license agreement with Verve, including rights to co-develop and co-commercialize Verve&#39;s base editing programs for cardiovascular disease.</li>
<li>BioVie Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bivi#NASDAQ">BIVI</a>) rose 23.6% to $4.7840.</li>
<li>Wolfspeed, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wolf#NYSE">WOLF</a>) jumped 22.7% to $34.02 after the company reported first-quarter earnings.</li>
<li>Repligen Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgen#NASDAQ">RGEN</a>) gained 20.5% to $137.65 following better-than-expected results.</li>
<li>Mullen Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/muln#NASDAQ">MULN</a>) rose 20.1% to $0.3051.</li>
<li>YanGuFang International Group Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ygf#NASDAQ">YGF</a>) gained 19.5% to $2.81.</li>
<li>Shutterstock, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sstk#NYSE">SSTK</a>) climbed 18.6% to $40.71 after the company posted upbeat third-quarter results and raised FY23 outlook.</li>
<li>Harmony Biosciences Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hrmy#NASDAQ">HRMY</a>) rose 17.7% to $23.21 following third-quarter results.</li>
<li>Avalo Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avtx#NASDAQ">AVTX</a>) shares gained 17.5% to $0.1090 after the company announced it has completed the divestiture of AVTX-800 Series.</li>
<li>Pinterest, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pins#NYSE">PINS</a>) shares rose 16.9% to $29.34 after the company reported better-than-expected third-quarter financial results and issued guidance.</li>
<li>Two Harbors Investment Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/two#NYSE">TWO</a>) climbed 16.8% to $11.74 following quarterly results.</li>
<li>Conduit Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdt#NASDAQ">CDT</a>) rose 16.5% to $1.83.</li>
<li>Femasys Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/femy#NASDAQ">FEMY</a>) gained 16.5% to $1.62.</li>
<li>Modular Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/modd#NASDAQ">MODD</a>) jumped 15% to $1.23.</li>
<li>Evaxion Biotech A/S (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evax#NASDAQ">EVAX</a>) climbed 14.8% to $1.09.</li>
<li>Insperity, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nsp#NYSE">NSP</a>) gained 14.3% to $110.31 following upbeat results.</li>
<li>EUDA Health Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/euda#NASDAQ">EUDA</a>) rose 14.2% to $0.86.</li>
<li>Perficient, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prft#NASDAQ">PRFT</a>) gained 13.6% to $58.51 following strong quarterly sales.</li>
<li>Granite Construction Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gva#NYSE">GVA</a>) jumped 13.4% to $38.92 following strong quarterly results.</li>
<li>The Vita Coco Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coco#NASDAQ">COCO</a>) gained 12.7% to $26.34 following upbeat earnings.</li>
<li>Beam Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/beam#NASDAQ">BEAM</a>) climbed 12.5% to $21.50 after Eli Lilly agreed to acquire certain rights under Beam&#39;s agreement with Verve Therapeutics.</li>
<li>Pulmonx Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lung#NASDAQ">LUNG</a>) gained 12.2% to $8.85 as the company posted third-quarter results and raised 2023 revenue outlook.</li>
<li>Otter Tail Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ottr#NASDAQ">OTTR</a>) rose 11.3% to $77.63 after the company posted third-quarter results and raised 2023 EPS guidance.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnaz#NASDAQ">RNAZ</a>) shares gained 11.2% to $0.4001 after the company announced it is withdrawing the underwritten public offering of its common stock.</li>
<li>Arista Networks, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/anet#NYSE">ANET</a>) rose 10.8% to $194.69 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates.</li>
<li>Ryerson Holding Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ryi#NYSE">RYI</a>) climbed 8.2% to $29.76 following third-quarter results.</li>
<li>Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/shph#NASDAQ">SHPH</a>) rose 5.5% to $0.4908. On Oct. 24, 2023, Shuttle Pharmaceuticals entered into an exclusive licensing agreement with Georgetown University.</li>
<li>HomeStreet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hmst#NASDAQ">HMST</a>) gained 3.1% to $4.71 following better-than-expected third-quarter earnings.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Kintara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktra#NASDAQ">KTRA</a>) shares dipped 76.7% to $0.8901. The company announced that its drug VAL-083 did not outperform existing treatments for glioblastoma, a severe brain cancer.</li>
<li>Galera Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grtx#NASDAQ">GRTX</a>) fell 55.8% to $0.0934 after the company said GRECO-2 trial did not pass futility analysis.</li>
<li>reAlpha Tech Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aire#NASDAQ">AIRE</a>) fell 53.5% to $23.17.</li>
<li>Sientra, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sien#NASDAQ">SIEN</a>) declined 48% to $0.76 after the company reported preliminary unaudited third-quarter financial results.</li>
<li>Sarepta Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srpt#NASDAQ">SRPT</a>) fell 42.3% to $62.16 after the company said EMBARK did not meet the primary endpoint.</li>
<li>Avenue Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atxi#NASDAQ">ATXI</a>) declined 34.4% to $0.23 as the company announced pricing of $5 million public offering.</li>
<li>PetMed Express, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pets#NASDAQ">PETS</a>) fell 33.2% to $6.14 after reporting weaker-than-expected second-quarter sales.</li>
<li>Tempo Automation Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmpo#NASDAQ">TMPO</a>) shares fell 32.8% to $0.08. Tempo Automation recently announced commencement of Nasdaq delisting proceedings.</li>
<li>CarParts.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prts#NASDAQ">PRTS</a>) fell 22.2% to $2.6050 following weak quarterly sales.</li>
<li>GeneDx Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wgs#NASDAQ">WGS</a>) declined 21.7% to $2.0901 following quarterly results.</li>
<li>Bit Brother Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bets#NASDAQ">BETS</a>) fell 19.2% to $0.0468 after declining around 14% on Monday. The company recently reported pricing of $5.04 million registered direct offering.</li>
<li>Lattice Semiconductor Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lscc#NASDAQ">LSCC</a>) shares fell 18.2% to $55.07 after the company reported third-quarter financial results and issued weak sales forecast for the fourth quarter.</li>
<li>Annovis Bio, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/anvs#NYSE">ANVS</a>) shares fell 16.7% to $6.79 after the company announced launch of a proposed public offering.</li>
<li>Spirit Airlines, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/save#NYSE">SAVE</a>) dipped 16.2% to $10.94 following quarterly results.</li>
<li>Catalent, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctlt#NYSE">CTLT</a>) fell 16% to $33.54.</li>
<li>Dorman Products, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dorm#NASDAQ">DORM</a>) declined 16% to $61.14 after the company posted downbeat earnings and lowered FY23 outlook.</li>
<li>JetBlue Airways Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jblu#NASDAQ">JBLU</a>) tumbled 14.2% to $3.5999 after reporting third-quarter results. The company also said it sees a wider loss for FY23.</li>
<li>TETRA Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tti#NYSE">TTI</a>) fell 14.2% to $4.79 following weak quarterly results.</li>
<li>Chegg, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chgg#NYSE">CHGG</a>) fell 12.7% to $7.74 after the company reported third-quarter financial results and issued fourth-quarter guidance.</li>
<li>Orgenesis Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/orgs#NASDAQ">ORGS</a>) fell 12.4% to $0.71. Orgenesis announced withdrawal of its earlier announced proposed underwritten public offering due to market conditions.</li>
<li>ZoomInfo Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zi#NASDAQ">ZI</a>) dipped 12% to $13.66 following quarterly results.</li>
<li>e.l.f. Beauty, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/elf#NYSE">ELF</a>) declined 11.9% to $90.81.</li>
<li>PriceSmart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psmt#NASDAQ">PSMT</a>) dipped 11.2% to $63.65 following weak earnings.</li>
<li>V.F. Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vfc#NYSE">VFC</a>) shares fell 11.2% to $15.21 after the company reported downbeat second-quarter earnings and withdrew its full-year guidance.</li>
<li>Hubbell Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hubb#NYSE">HUBB</a>) declined 10.5% to $253.63 following weak earnings.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) shares fell 7.7% to $0.7201 after surging around 38% on Monday.</li>
<li>BP p.l.c. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bp#NYSE">BP</a>) shares fell 5.2% to $36.33 following weaker-than-expected third-quarter profit.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/23/10/35510705/top-3-consumer-stocks-that-could-sink-your-portfolio-in-q4"> Top 3 Consumer Stocks That Could Sink Your Portfolio In Q4</a>

AIRE

ANET

ANVS

ATXI

AVTX

BETS

BIVI

CHGG

COCO

CTLT

DORM

Euda Health Holdings Limited - Ordinary Shares

EUDA

EVAX

FEMY

GRTX

HMST

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HRMY

HUBB

JBLU

Kintara Therapeutics, Inc. - Common Stock

KTRA

LSCC

LUNG

MODD

MULN

ORGS

OTTR

PETS

PINS

PRFT

PRTS

Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session